R&D Executives Seek China Role In Clinical Development

 
• By Brian Yang

What excites R&D heads and executives when it comes to China? Regulatory reforms, certainly, but emerging technologies including AI could position China for a bigger play, going by discussions at a recent forum that saw AstraZeneca, Sanofi, Beigene and Jiangsu Hengrui executives debate future biopharma development in China.

Sanofi, AZ R&D heads among panelists at Wuxi Healthcare Forum, held 3/3-6 in Shanghai
Sanofi, AZ R&D executives among panelists at Wuxi Healthcare Forum, held in Shanghai • Source: courtesy of Wuxi Apptec

More from R&D

More from Scrip